Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

George Papatheodoridis

Showing results (121-130 of 138) with videos related to

Pageof 14
Sort By:
Liver International : Official Journal of the International Association for the Study of the Liver|June 16, 2025
HERACLIS_BLV_D: Increasing Response Rates During 2-Year Bulevirtide Real-Life Therapy in Chronic Hepatitis DMargarita Papatheodoridi, Vasilios Sevastianos, Kalliopi Zachou, et al.
European Journal of Gastroenterology & Hepatology|September 26, 2024
Pregnancy outcomes in Greek women with inflammatory bowel disease: a longitudinal national retrospective studyEvgenia Papathanasiou, Georgios Kokkotis, Georgios Axiaris, et al.
Journal of Hepatology|April 1, 2026
Long-term outcomes after nucleos(t)ide analogue cessation in chronic hepatitis B - follow-up from the RETRACT-B cohortEdo Dongelmans, Grishma Hirode, Florian van Bӧmmel, et al.
European Journal of Gastroenterology & Hepatology|August 17, 2021
The natural history of COVID-19 in patients with inflammatory bowel disease: a nationwide study by the Hellenic Society for the study of IBDGiorgos Bamias, Georgios Kokkotis, Angeliki Christidou, et al.
BMC Gastroenterology|June 30, 2021
The burden and management of anemia in Greek patients with inflammatory bowel disease: a retrospective, multicenter, observational studyKalliopi Foteinogiannopoulou, Konstantinos Karmiris, Georgios Axiaris, et al.
Journal of Hepatology|July 25, 2020
aMAP risk score predicts hepatocellular carcinoma development in patients with chronic hepatitisRong Fan, George Papatheodoridis, Jian Sun, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 3, 2025
Risk Factors of Metabolic Dysfunction-associated Steatotic Liver Disease in a Cohort of Patients With Chronic Hepatitis BMaria Kalafateli, Roberta Forlano, Eleanor Barnes, et al.
Gut|March 2, 2026
Colorectal cancer in metabolic dysfunction-associated steatotic liver disease: an international Delphi consensus statementChu-Tian Wu, Giovanni Targher, Christopher D Byrne, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 10, 2018
Range of Normal Liver Stiffness and Factors Associated With Increased Stiffness Measurements in Apparently Healthy IndividualsFateh Bazerbachi, Samir Haffar, Zhen Wang, et al.
Journal of Hepatology|January 10, 2025
Real-world effectiveness and safety of bulevirtide monotherapy for up to 96 weeks in patients with HDV-related cirrhosisElisabetta Degasperi, Maria Paola Anolli, Mathias Jachs, et al.
Pageof 14

Showing results (121-130 of 138) with videos related to

Sort By:
Pageof 14
Liver International : Official Journal of the International Association for the Study of the Liver|June 16, 2025
HERACLIS_BLV_D: Increasing Response Rates During 2-Year Bulevirtide Real-Life Therapy in Chronic Hepatitis DMargarita Papatheodoridi, Vasilios Sevastianos, Kalliopi Zachou, et al.
European Journal of Gastroenterology & Hepatology|September 26, 2024
Pregnancy outcomes in Greek women with inflammatory bowel disease: a longitudinal national retrospective studyEvgenia Papathanasiou, Georgios Kokkotis, Georgios Axiaris, et al.
Journal of Hepatology|April 1, 2026
Long-term outcomes after nucleos(t)ide analogue cessation in chronic hepatitis B - follow-up from the RETRACT-B cohortEdo Dongelmans, Grishma Hirode, Florian van Bӧmmel, et al.
European Journal of Gastroenterology & Hepatology|August 17, 2021
The natural history of COVID-19 in patients with inflammatory bowel disease: a nationwide study by the Hellenic Society for the study of IBDGiorgos Bamias, Georgios Kokkotis, Angeliki Christidou, et al.
BMC Gastroenterology|June 30, 2021
The burden and management of anemia in Greek patients with inflammatory bowel disease: a retrospective, multicenter, observational studyKalliopi Foteinogiannopoulou, Konstantinos Karmiris, Georgios Axiaris, et al.
Journal of Hepatology|July 25, 2020
aMAP risk score predicts hepatocellular carcinoma development in patients with chronic hepatitisRong Fan, George Papatheodoridis, Jian Sun, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 3, 2025
Risk Factors of Metabolic Dysfunction-associated Steatotic Liver Disease in a Cohort of Patients With Chronic Hepatitis BMaria Kalafateli, Roberta Forlano, Eleanor Barnes, et al.
Gut|March 2, 2026
Colorectal cancer in metabolic dysfunction-associated steatotic liver disease: an international Delphi consensus statementChu-Tian Wu, Giovanni Targher, Christopher D Byrne, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 10, 2018
Range of Normal Liver Stiffness and Factors Associated With Increased Stiffness Measurements in Apparently Healthy IndividualsFateh Bazerbachi, Samir Haffar, Zhen Wang, et al.
Journal of Hepatology|January 10, 2025
Real-world effectiveness and safety of bulevirtide monotherapy for up to 96 weeks in patients with HDV-related cirrhosisElisabetta Degasperi, Maria Paola Anolli, Mathias Jachs, et al.
Pageof 14